Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Wushi Medical Research Institute is a Chinese biotechnology and medical research organization headquartered in Wuhan. The institute specializes in the research, development, and clinical evaluation of Traditional Chinese Medicine (TCM) formulations and integrated medical solutions. Its primary focus areas include gynecological conditions and respiratory diseases, with a pipeline featuring proprietary herbal decoctions like Wushi Huayu and Wushi Jiedu. In addition to therapeutic research, the institute provides technical consulting services and engages in the distribution of medical devices. The organization plays a role in the modernization of traditional therapies through structured clinical trials and technical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Wushi Medical Research Institute.